Obviously not a whole lot that can be taken from this ann, but I’m wondering if this points to some positive signs of the FDA meeting, “highlighting the growing global interest in the Company’s new class of antibiotics”, perhaps there was a good outcome and they need to drum up investor interest for the next step?
Just speculation obviously, but the only reason there would be “growing global interest” would be if the FDA discussion was positive, just my thinking, could be reading into it too much.
Obviously not a whole lot that can be taken from this ann, but...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.080(21.9%) |
Mkt cap ! $128.6M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 44.5¢ | 37.5¢ | $191.2K | 477.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12222 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 10976 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |